Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
JCI Insight ; 3(9)2018 05 03.
Article in English | MEDLINE | ID: mdl-29720568

ABSTRACT

Fibrosis is the end result of most inflammatory conditions, but its pathogenesis remains unclear. We demonstrate that, in animals and humans with systemic fibrosis, plasmacytoid DCs (pDCs) are unaffected or are reduced systemically (spleen/peripheral blood), but they increase in the affected organs (lungs/skin/bronchoalveolar lavage). A pivotal role of pDCs was shown by depleting them in vivo, which ameliorated skin and/or lung fibrosis, reduced immune cell infiltration in the affected organs but not in spleen, and reduced the expression of genes and proteins implicated in chemotaxis, inflammation, and fibrosis in the affected organs of animals with bleomycin-induced fibrosis. As with animal findings, the frequency of pDCs in the lungs of patients with systemic sclerosis correlated with the severity of lung disease and with the frequency of CD4+ and IL-4+ T cells in the lung. Finally, treatment with imatinib that has been reported to reduce and/or prevent deterioration of skin and lung fibrosis profoundly reduced pDCs in lungs but not in peripheral blood of patients with systemic sclerosis. These observations suggest a role for pDCs in the pathogenesis of systemic fibrosis and identify the increased trafficking of pDCs to the affected organs as a potential therapeutic target in fibrotic diseases.


Subject(s)
Dendritic Cells/pathology , Fibrosis/pathology , Lung/pathology , Scleroderma, Systemic/pathology , Skin/pathology , Adult , Animals , Antibiotics, Antineoplastic/adverse effects , Bleomycin/adverse effects , Bronchoalveolar Lavage Fluid/cytology , CD4-Positive T-Lymphocytes/metabolism , Case-Control Studies , Chemokines/genetics , Chemotaxis/genetics , Disease Models, Animal , Female , Fibrosis/chemically induced , Fibrosis/genetics , Fibrosis/immunology , Gene Expression , Humans , Imatinib Mesylate/therapeutic use , Inflammation/genetics , Interleukin-4/metabolism , Male , Mice , Protein Kinase Inhibitors/therapeutic use , Receptors, Chemokine/genetics , Scleroderma, Systemic/blood , Scleroderma, Systemic/drug therapy , Scleroderma, Systemic/immunology , Severity of Illness Index , Spleen/pathology , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , Young Adult
2.
Clin Immunol ; 141(3): 293-303, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22015344

ABSTRACT

T cells, particularly those producing IL-4, are implicated in inflammation-mediated fibrosis. In our phase I/IIa open-label pilot study in 15 patients with scleroderma-interstitial lung disease (SSc-ILD), high-dose imatinib treatment showed modest improvement in lung function and skin score, but with several adverse events. Here, we investigated T cell phenotype and cytokine production in bronchoalveolar lavage (BAL) from patients enrolled in this trial. We found that IL-4(+) T cells showed a stronger correlation with ground glass opacity (GGO) than fibrosis scores on lung high-resolution computer tomography scans. Frequencies of IL-4(+) T cells also discriminated patients with high (≥20) versus low (<20) GGO scores. Functional annotation clustering of proteins that correlated with T cells identified two major clusters that belonged to immune/inflammatory and wounding response. Repeat analyses after 1 year of treatment in 10 BAL samples, one each from the right middle and lower lobes of lung from 5 patients, showed that post-imatinib, IL-4(+) T cells were profoundly reduced but CD4(+) T cells increased, except in one patient who showed worsening of SSc-ILD. Post-imatinib increase in CD4(+) T cells correlated with soluble ICAM-3 and PECAM-1 levels in BAL, which associated with the lack of worsening in SSc-ILD. Thus, imatinib might confer its therapeutic effect in fibrosis via re-directing T cell responses from type 2 to other, non-type 2 cytokine producing CD4(+) T cells.


Subject(s)
Bronchoalveolar Lavage Fluid/immunology , CD4-Positive T-Lymphocytes/drug effects , Interleukin-4/immunology , Piperazines/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Scleroderma, Systemic/drug therapy , Adult , Antigens, CD/analysis , Antigens, CD/immunology , Benzamides , CD4-Positive T-Lymphocytes/immunology , Cell Adhesion Molecules/analysis , Cell Adhesion Molecules/immunology , Clinical Trials, Phase II as Topic , Female , Humans , Imatinib Mesylate , Lung/diagnostic imaging , Lung/immunology , Male , Middle Aged , Pilot Projects , Platelet Endothelial Cell Adhesion Molecule-1/analysis , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Radiography , Scleroderma, Systemic/diagnostic imaging , Scleroderma, Systemic/immunology
3.
J Immunol ; 186(2): 924-30, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-21149603

ABSTRACT

Systemic lupus erythematosus is a chronic autoimmune disease characterized by loss of tolerance to self-Ags and activation of autoreactive T cells. Regulatory T (Treg) cells play a critical role in controlling the activation of autoreactive T cells. In this study, we investigated mechanisms of potential Treg cell defects in systemic lupus erythematosus using MRL-Fas(lpr/lpr) (MRL/lpr) and MRL-Fas(+/+) mouse models. We found a significant increase in CD4(+)CD25(+)Foxp3(+) Treg cells, albeit with an altered phenotype (CD62L(-)CD69(+)) and with a reduced suppressive capacity, in the lymphoid organs of MRL strains compared with non-autoimmune C3H/HeOuj mice. A search for mechanisms underlying the altered Treg cell phenotype in MRL/lpr mice led us to find a profound reduction in Dicer expression and an altered microRNA (miRNA, miR) profile in MRL/lpr Treg cells. Despite having a reduced level of Dicer, MRL/lpr Treg cells exhibited a significant overexpression of several miRNAs, including let-7a, let-7f, miR-16, miR-23a, miR-23b, miR-27a, and miR-155. Using computational approaches, we identified one of the upregulated miRNAs, miR-155, that can target CD62L and may thus confer the altered Treg cell phenotype in MRL/lpr mice. In fact, the induced overexpression of miR-155 in otherwise normal (C3H/HeOuj) Treg cells reduced their CD62L expression, which mimics the altered Treg cell phenotype in MRL/lpr mice. These data suggest a role of Dicer and miR-155 in regulating Treg cell phenotype. Furthermore, simultaneous appearance of Dicer insufficiency and miR-155 overexpression in diseased mice suggests a Dicer-independent alternative mechanism of miRNA regulation under inflammatory conditions.


Subject(s)
DEAD-box RNA Helicases/deficiency , DEAD-box RNA Helicases/genetics , Endoribonucleases/deficiency , Endoribonucleases/genetics , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/pathology , MicroRNAs/biosynthesis , MicroRNAs/genetics , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology , Animals , Computational Biology/methods , DEAD-box RNA Helicases/physiology , Endoribonucleases/physiology , Immunophenotyping , Inflammation/genetics , Inflammation/immunology , Inflammation/pathology , Lupus Erythematosus, Systemic/genetics , Lymphoid Tissue/immunology , Lymphoid Tissue/metabolism , Lymphoid Tissue/pathology , Mice , Mice, Inbred C3H , Mice, Inbred MRL lpr , MicroRNAs/physiology , Ribonuclease III , T-Lymphocytes, Regulatory/metabolism
4.
Comput Methods Programs Biomed ; 92(1): 54-65, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18644656

ABSTRACT

The Elispot effectively measures the frequencies of cells secreting particular molecules, especially low-frequency cells such as antigen-specific T cells. The Fluorospot assay adapted this analysis to two products per cell, and this has now been extended to three-color measurement of both mouse and human cytokine-secreting cells. Due to the increased data complexity, and particularly the need to define single-, double- and triple-producing cells, it is critical to objectively quantify spot number, size, intensity, and coincidence with other spots. An automated counting program, Exploraspot, was therefore developed to detect and quantify Fluorospots in automated fluorescence microscope images. Morphological parameters, including size, intensity, location, circularity and others are calculated for each spot, exported in FCS format, and further analyzed by gating and graphical display in popular flow cytometry analysis programs. The utility of Exploraspot is demonstrated by identification of single-, double- and triple-secreting T cells; tolerance of variable background fluorescence; and estimation of the numbers of genuine versus random multiple events.


Subject(s)
Artificial Intelligence , Cytokines/metabolism , Gene Expression Profiling/methods , Image Interpretation, Computer-Assisted/methods , Lymphocytes/metabolism , Microscopy, Fluorescence, Multiphoton/methods , Pattern Recognition, Automated/methods , Algorithms , Animals , Cells, Cultured , Lymphocytes/cytology , Mice
5.
J Exp Med ; 205(5): 1099-108, 2008 May 12.
Article in English | MEDLINE | ID: mdl-18443225

ABSTRACT

Most autoimmune diseases are more common in women than in men. This may be caused by differences in sex hormones, sex chromosomes, or both. In this study, we determined if there was a contribution of sex chromosomes to sex differences in susceptibility to two immunologically distinct disease models, experimental autoimmune encephalomyelitis (EAE) and pristane-induced lupus. Transgenic SJL mice were created to permit a comparison between XX and XY within a common gonadal type. Mice of the XX sex chromosome complement, as compared with XY, demonstrated greater susceptibility to both EAE and lupus. This is the first evidence that the XX sex chromosome complement, as compared with XY, confers greater susceptibility to autoimmune disease.


Subject(s)
Autoimmune Diseases/genetics , Chromosomes, Human, X , Chromosomes, Human, Y , Complement System Proteins/genetics , Animals , Autoantibodies/blood , Castration , Female , Genetic Predisposition to Disease , Humans , Immunization , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Nephritis/genetics , Nephritis/immunology , Ovariectomy , Sex Chromosomes
6.
J Infect Dis ; 195(12): 1779-88, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17492594

ABSTRACT

BACKGROUND: Respiratory syncytial virus (RSV) infection is the most common respiratory viral infection resulting in hospitalizations in infants worldwide. Illness severity is likely multifactorial; however, unlike other viral infections, both type 1 and type 2 cytokine responses have been implicated in severe disease. METHODS: We measured RSV-specific cytokine responses ex vivo during primary RSV infection in the blood of 18 infants with polymerase chain reaction-confirmed RSV infection. To focus on primary RSV infection, subjects were all<9 months old. RSV-specific cytokine responses were measured at 3 time points during acute primary RSV infection and at 1 memory time point 3-6 months later. RESULTS: RSV-specific interferon (IFN)- gamma responses were detected in 10 of 18 of infants. Infants with mild disease had higher RSV-specific IFN- gamma memory responses than did those with moderate or severe disease. No consistent correlations between RSV-specific IFN- gamma responses and corticosteroid administration were observed. RSV-specific interleukin (IL)-4 or IL-5 responses to primary RSV infection were detectable in 5 of 18 and 8 of 15 infants, respectively. CONCLUSIONS: During primary RSV infection, many infants demonstrated RSV-specific IFN- gamma responses. The strongest IL-4 and IL-5 responses were detected in 3 infants with severe disease, suggesting that type 2 responses may contribute to the pathogenesis of severe disease.


Subject(s)
Interferon-gamma/metabolism , Leukocytes, Mononuclear/immunology , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Virus, Human/immunology , Respiratory Tract Infections/immunology , Female , Humans , Infant , Interferon-gamma/blood , Interleukin-4/metabolism , Interleukin-5/metabolism , Leukocytes, Mononuclear/virology , Male , Phytohemagglutinins/immunology , Polymerase Chain Reaction , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/virology , Severity of Illness Index , Time Factors
7.
J Immunol ; 176(4): 2662-8, 2006 Feb 15.
Article in English | MEDLINE | ID: mdl-16456029

ABSTRACT

CD8(+) T cells in HIV-infected patients are believed to contribute to the containment of the virus and the delay of disease progression. However, the frequencies of HIV-specific CD8(+) T cells, as measured by IFN-gamma secretion and tetramer binding, often do not correlate with a delay in disease progression during chronic infection. Using the Lysispot and ELISPOT assays, we measured the frequencies of cytotoxic and IFN-gamma-secreting T cells responding to overlapping peptides from Gag, Nef, Env, and Pol consensus HIV-1 clade B sequences. PBMC from the majority of HIV-infected subjects have significant frequencies of HIV-specific cells that killed targets within 5 h directly ex vivo. The relative frequencies of IFN-gamma-secreting and cytotoxic cells varied markedly between different HIV peptide pools within the same patient, and some T cells lysed targets without secreting IFN-gamma. These results indicate that measurement of IFN-gamma production alone may be insufficient to evaluate the breadth of the HIV-specific T cell response. Also, neither the CTL to IFN-gamma ratios nor the ex vivo CTL frequencies specific for different HIV proteins were consistently lower than responses specific for two other chronic viral infections, human CMV and EBV, within the same subjects. Thus ex vivo cytotoxic T cell frequencies do not provide evidence for a model of "preterminal differentiation" of HIV-specific CD8(+) T cells during chronic HIV infection. Analysis of the frequency of directly cytotoxic HIV-specific T cells may be of considerable value in the assessment of disease progression and the potential efficacy of HIV vaccines.


Subject(s)
HIV Infections/immunology , HIV Infections/virology , HIV-1/immunology , Interferon-gamma/metabolism , Lymphocyte Count/methods , T-Lymphocytes, Cytotoxic/cytology , T-Lymphocytes, Cytotoxic/immunology , Adult , Cells, Cultured , Chronic Disease , Cytomegalovirus/immunology , Female , Herpesvirus 4, Human/immunology , Humans , Male , Middle Aged , Peptides/immunology , T-Lymphocytes, Cytotoxic/metabolism
8.
J Immunol ; 176(3): 1465-73, 2006 Feb 01.
Article in English | MEDLINE | ID: mdl-16424174

ABSTRACT

Mouse and human CD4 T cells primed during an immune response may differentiate into effector phenotypes such as Th1 (secreting IFN-gamma) or Th2 (secreting IL-4) that mediate effective immunity against different classes of pathogen. However, primed CD4 T cells can also remain uncommitted, secreting IL-2 and chemokines, but not IFN-gamma or IL-4. We now show that human CD4 T cells primed by protein vaccines mostly secreted IL-2, but not IFN-gamma, whereas in the same individuals most CD4 T cells initially primed by infection with live pathogens secreted IFN-gamma. We further demonstrate that many tetanus-specific IL-2+IFN-gamma- cells are uncommitted and that a single IL-2+IFN-gamma- cell can differentiate into Th1 or Th2 phenotypes following in vitro stimulation under appropriate polarizing conditions. In contrast, influenza-specific IL-2+IFN-gamma- CD4 cells maintained a Th1-like phenotype even under Th2-polarizing conditions. Similarly, adoptively transferred OTII transgenic mouse T cells secreted mainly IL-2 after priming with OVA in alum, but were biased toward IFN-gamma secretion when primed with the same OVA peptide presented as a pathogen Ag during live infection. Thus, protein subunit vaccines may prime a unique subset of differentiated, but uncommitted CD4 T cells that lack some of the functional properties of committed effectors induced by infection. This has implications for the design of more effective vaccines against pathogens requiring strong CD4 effector T cell responses.


Subject(s)
Bacterial Infections/immunology , CD4-Positive T-Lymphocytes/metabolism , Cell Differentiation/immunology , Interferon-gamma/metabolism , Interleukin-2/metabolism , Vaccines, Subunit/immunology , Virus Diseases/immunology , Adult , Animals , Bacterial Infections/metabolism , Bacterial Infections/prevention & control , Base Sequence , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , Cells, Cultured , Female , Humans , Immunologic Memory , Listeria monocytogenes/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Middle Aged , Molecular Sequence Data , T-Lymphocyte Subsets/transplantation , Tetanus Toxoid/immunology , Vaccines, Subunit/administration & dosage , Virus Diseases/metabolism , Virus Diseases/prevention & control
9.
Int J Cancer ; 117(4): 574-86, 2005 Nov 20.
Article in English | MEDLINE | ID: mdl-15912532

ABSTRACT

We investigated the role of B cells in tumor immunity by studying immune responses of mice genetically lacking B cells to primary tumors. IgM(-/-) B cell-deficient mice (BCDM) exhibited enhanced resistance to 3 histologically diverse syngeneic tumors as compared to the wild-type (WT) mice. EL4 thymoma and MC38 colon carcinoma grew progressively in WT mice, but regressed spontaneously in BCDM whereas growth of B16 melanoma was slowed significantly in BCDM as compared to the WT mice. BCDM exhibited increased T cell infiltration of tumors, higher T(H)1 cytokine response and, in the case of MC38, a higher anti-tumor CTL response. The increased tumor resistance of BCDM did not seem to result from intrinsic changes in their non-B immunocytes because adoptive transfer of WT splenic B cells to BCDM abrogated tumor rejection and resulted in diminished anti-tumor T(H)1 cytokine and CTL responses. Studies involving BCR-transgenic mice indicated that B cells may inhibit anti-tumor T cell responses by antigen-nonspecific mechanisms since neither tumor-specific antibodies nor cognate T:B interactions were necessary for inhibition of tumor immunity by B cells. IFN-gamma secretion in splenocyte:tumor co-cultures of tumor-challenged BCDM was inhibited by WT but not CD40(-/-) B cells indicating that B cells may inhibit anti-tumor T(H)1 cytokine responses in a CD40-dependent manner. Adoptive transfer of CD40(-/-) B cells into BCDM resulted in restored growth of MC38 suggesting additional factors other than CD40 are involved in dampening anti-tumor responses. The effects of B cells on anti-tumor response warrant further study.


Subject(s)
B-Lymphocytes/immunology , Cytokines/biosynthesis , Lymphocyte Depletion , Neoplasms, Experimental/immunology , T-Lymphocytes, Cytotoxic/immunology , Th1 Cells/immunology , Animals , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Mice , Mice, Transgenic , Neoplasms, Experimental/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...